Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s 2025 annual meeting of stockholders ...

Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4, ...

A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at About CeriBell, Inc. Ceribell is a medical technology company focused on ...

InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free ...

BOCA RATON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it ...

For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on November 6, 2025, either at www.steris-ir.com or via phone. To access the replay of the ...

Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the third quarter 2025 financial and business results on Tuesday, November 4, 2025, ...

The FALCON Phase 2 trial is a U.S.-based, multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of TERN-601, a novel oral GLP-1R agonist, with once-daily ...

Event: UBS Global Healthcare Conference Location: Palm Beach Gardens, FL Date: November 10 and 11, 2025 Event Format: 1-on-1 institutional investor meetings only Company Participants: Robert Leasure ...

A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the ...

Leerink Partners, TD Cowen, Guggenheim Securities, Wells Fargo Securities and LifeSci Capital are acting as joint bookrunning managers for the proposed offering. H.C. Wainwright & Co. and Clear Street ...

David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Second Annual Healthcare Innovation Conference in Boston, MA on Wednesday, ...